A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in IGRA Positive Adolescents and Adults Living in a TB Endemic Region.

Conditions: Tuberculosis (TB) Interventions: Biological: MTBVAC; Biological: Placebo Sponsors: International AIDS Vaccine Initiative; Biofabri, SLU; Universidad de Zaragoza Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials